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1. Introduction 
Acute pancreatitis is an inflammatory condition with a variable clinical course from mild to 
the most severe with serious complications that attempt the life of a patient. According to 
the Atlanta classifications the severe acute pancreatitis occurs approximately at 25% of all 
patients with acute pancreatitis and it is associated with 10-20% of mortality. Death of the 
acute pancreatitis patients is often connected of at least one organ. 
There are two phases of the severe acute pancreatitis relating to the mortality. The first 
phase, two weeks after onset of syndrome, is characterized by hypovolemia or even by the 
shock. It is accompanied by the systemic inflammatory responsive syndrome with 
production of inflammatory mediators and cytokines, which cause consecutive injury of 
lungs, livers and cardiovascular system. The multi organ failure is a very common 
appearance in the case of the severe acute pancreatitis and it happens very often even when 
the infection is absent. The second phase of this disease (third-forth week) is characterized 
by the complications caused by the infection of pancreatic necrosis. About 40-70% patients 
with necrotic acute pancreatitis is afflicted by the infection of the pancreatic necrosis, which 
causes the deaths of acute pancreatitis patients (Beger et al., 1997). The extent of the 
pancreatic necrosis and the duration of disease are the risk factors of the local pancreatic 
infection. Its incidence tends to culminate in third week of disease, though it may appear in 
whichever phase of the disease (Büchler et al., 2000). Severe acute pancreatitis requires 
treatment at the hospital, which is developed from personal, professional and technical 
point of view, where is a possibility to do the full diagnosis and therapy and the 
interdivisional cooperation, what is the basic presumption for treatment and diagnosis of 
acute pancreatitis.  
Diagnosis is based upon clinical presentation, laboratory indicates and imaging studies, 
whilst illness severity can be assessed by clinical scoring systems, such as Ranson, Glasgow 
or Apache II criteria, or by radiological assessments such as the computer tomography 
severity index. Mild disease is often self-limiting and inflammation resolves with simple 
medical management. However, a minority of patients (up to 20%) will develop severe 
disease that carries substantial morbidity and mortality.  
Over the past decades, management of severe acute pancreatitis changed from an early 
operative treatment to a more conservative approach. Nowadays there is clearly no more 
doubt that surgery is not the first choice of treatment for patients suffering from severe acute 
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pancreatitis. Surgical debridement is the gold standard in patients with infected pancreatic 
necrosis. By delaying surgery up to the third or fourth week, sufficient debridement can be 
achieved, resulting in low mortality and morbidity rates. Early enteral feeding is preferred 
over total parenteral nutrition as it results in a reduced incidence of infection, length of 
hospital stay and mortality.  
Besides full intensive treatment of acute pancreatitis there is a non changeable role of the 
surgical – operational treatment. Some indications for surgical treatment are no doubtful; 
some of them are the subject of discussion. The documented persistent infected necrosis and 
abscess is clear indication for the surgical treatment. Permanent acute abdomen, especially 
so called intra-abdominal compartment syndrome and persistent or increasing local 
complications (bleeding, ileus, bleeding of gastrointestinal tract, vascular ileus and others) 
are also the definite indication of the surgical intervention. Many authors consider the sterile 
necrosis, which causes the multi organ failure and which does not react to the maximal 
intensive treatment more than 72 hours, as an indicator of the surgical treatment (Götzinger, 
2007). 
The changes in the management of the patients with severe acute pancreatitis in the last 
decade contributed to the decrease of mortality. The aim of this study is to evaluate progress 
in the management of the patients with severe acute pancreatitis, comparing two clinical 
groups of patients.  
2. Changes in the management of treatment in acute pancreatitis patients 
Despite than mortality from severe acute pancreatitis has remarkably decreased (10-20%) 
during the last decades, many questions remain open about the treatment of this disease. 
Published literature on severe acute pancreatitis was reviewed and the decision to change 
the management of the treatment of severe acute pancreatitis has been made, at the First 
Department of Surgery, University Hospital in Košice, Slovakia. The management referred 
to the enteral nutrition, epidural analgesia, antibiotic prophylaxis, delay surgery to the later 
period in the case of infected necrosis.  
2.1 Enteral nutrition 
Enteral nutrition fed by the three-luminal tube applied by fibroscope, checking position by 
the contrast X-ray exam or by enteral nutrition through jejunostomy, in the case of already 
operated patient. 
In 1997, McClave et al. demonstrated that nasojejunal feeding is a safe and beneficial 
method in mild and moderate pancreatitis (McClave et al., 1997). Later on, Nakad et al. 
found that nasojejunal feeding is feasible in severe acute pancreatitis, too (Nakad et al., 
1998). Recently, some questioned whether nasojejunal feeding is the only proper route of 
enteral feeding in acute pancreatitis. The main disadvantage of nasojejunal feeding that it 
requires an endoscopist or radiologist to place the tube in, which may cause some delay in 
starting early enteral feeding (Spanier et al., 2011). Piciucchi et al. have found that enteral 
nutrition administered by nasogastric or nasojejunal tube seems to provide equal safety, 
tolerability and efficacy, even if more results are necessary to validate the routine use of 
nasogastric tubes in severe acute pancreatitis patients (Piciucchi et al., 2010). 
One of the most common complications of enteral feeding is diarrhea, which can be detected 
in 20–30% of all patients. Diarrhea may deteriorate volume depletion and dehydration 
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resulting in further weakening of the general condition of patients who are very sick 
anyway and usually need intensive care management. Wide-spectrum antibiotics, which are 
frequently used in severe acute pancreatitis, can contribute to the development of diarrhea 
as a significant additional factor (Whelan, 2007). It is possible that fiber enteral nutrition 
formulas have some preventive effect against diarrhea though (Elia et al., 2008). This 
observation was supported by a recently published study by Karakan et al. showed that 
prebiotic fiber supplementation reduced complication rate in acute pancreatitis in 
comparison to standard enteral solution (Karakan et al., 2007). A meta-analysis published by 
Petrov and Zagainov, which was based on six randomized control trials comparing enteral 
nutrition with parenteral nutrition, showed that enteral nutrition statistically significantly 
reduced the risk of hyperglycemia (p=0.04) as well as insulin requirement  (p=0.001), so it is 
associated with better blood glucose control in severe acute pancreatitis patients (Petrov & 
Zagainov, 2007). The facts that enteral nutrition is most likely superior to parenteral 
nutrition in preventing septic complications of acute pancreatitis, it may also eliminate some 
complications of parenteral nutrition (catheter sepsis, pneumothorax, and thrombosis), and 
costs only 15% of the cost of total parenteral nutrition, make it an increasingly accepted 
treatment modality (Olah & Romics, 2010).  
Composition of enteral formulas can be classified into three basic categories: polymeric, 
(semi)elemental, and immunoenhanced. While polymeric nutrient comprises non-
hydrolyzed proteins, maltodextrins, oligofructosaccharides and long-chain triglycerides, 
(semi)elemental contains oligopeptides or amino-acids, maltodextrins, and medium and 
long-chain triglycerides. Theoretically, semi elemental nutrients stimulate pancreatic 
secretion in less extent, but enhance bowel absorption and those are tolerated better by 
patients than polymeric ones (Tiengou et al., 2006; Petrov et al., 2009b).  
Immunoenhanced nutrients involve substrates which modulate the activity of the immune 
system. Various immunonutrition formulas felt in this category, such as glutamine, arginine, 
and omega-3 fatty acids as well as enteral nutrients supplemented by probiotics. Recently, a 
meta-analysis compared (semi)elemental and polymeric formulations indirectly, using 10 
randomized controlled trials where parenteral nutrition was the reference treatment (Petrov 
et al., 2009a). The authors, however, could not demonstrate statistically significant difference 
with regard to tolerance of feeding, infectious complications, or mortality in between two 
enteral nutrition formulas (p=0.611). Enteral feeds with immune-enhancing ingredients such 
as glutamine, arginine, nucleotides, and omega-3 fatty acids that modulate the host immune 
and inflammatory response have recently attracted great interest (Bertolini et al., 2007). 
There are promising experimental studies, where supplementation of enteral feed with 
glutamine or omega-3 fatty acids could reduce the severity of experimental acute 
pancreatitis models (Foitzik et al., 2002; Rayes et al., 2009). Adding probiotics to enteral 
nutrients seemed to be a promising alternative for the future. In 10 of the 15 studies, 
probiotics significantly reduced bacterial infection rate compared to control groups. Two 
studies demonstrated a clear positive trend, but no statistical significance was detected 
(Olah & Romics, 2010). Sun et al., in a meta-analysis of four randomized controlled trials 
demonstrated that enteral feeding with probiotic could not reduce the infected necrosis (Sun 
et al., 2009). Eckerwall and Jacobson reported about timing when to resume oral feeding in 
patients with acute pancreatitis (Eckerwall et al., 2006; Jacobson et al., 2007). The usual 
criteria to initiate oral feeding are (1) absence of abdominal pain, (2) absence of nausea and 
vomiting, and return of appetite, and (3) absence of complications.  
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2.2 Antibiotics in acute pancreatitis 
Infection of pancreatic necrosis by enteric bacteria is the most common cause of death in 
patients with necrotizing pancreatitis. Progress in the therapeutic management of this 
disease has led to a decrease in the mortality of patients without infection of pancreatic 
necrosis, which commonly is reported to range between 5% and 15% (Tenner et al., 1997). 
Nevertheless, mortality rates of 20%-30% are reported in patients with infected pancreatic 
necrosis (Büchler et al., 2000). The clinical importance of pancreatic infection has led to the 
idea that the prevention of infected necrosis could be a beneficial approach.  
Antibiotics prophylaxis in severe acute pancreatitis has been a matter of discussion during 
the past years (Büchler et al., 2000; Slavin & Neoptolemos, 2001). Recent clinical studies 
seem to support the notion that early administration of broad-spectrum antibiotics is 
capable of reducing the incidence of infected pancreatic necrosis (Pederzoli et al., 1993; 
Golub et al., 1998; Sharma & Howden, 2001). Two randomized double-blind studies have 
addressed prophylactic antibiotics in patients with acute pancreatitis with prognostically 
severe and severe pancreatitis on imaging (Isenmann et al., 2004; Dellinger et al., 2007). 
These studies have failed to show any benefit from such drugs being routinely prescribed, 
no difference was found in the rate of pancreatic sepsis and mortality despite previous 
smaller non randomized studies suggesting a benefit. On the other hand, antibiotic overuse 
has been associated with up 30% of patients developing necrosis superinfection with 
Candida species which may confer a poorer prognosis (Büchler et al., 2000; Connor et al., 
2004). If antimicrobials are prescribed, the duration should to be limited to 14 days. 
Fourteen trials were included with a total of 841 patients in systematic review and meta-
analysis of antibiotic prophylaxis in severe acute pancreatitis by Wittau et al. The authors 
have investigated that the use of antibiotic prophylaxis was not associated with a 
statistically significant reduction in mortality, in the incidence of infected pancreatic 
necrosis, in the incidence of non-pancreatic infections, and in surgical interventions (Wittau 
et al., 2011).  
2.3 Epidural catheter 
Severe acute pancreatitis is associated with the development of local complications, such as 
pancreatic and peripancreatic necrosis, abscesses or pseudocysts, and systemic 
complications, such as adult respiratory distress syndrome or renal failure with mortality 
rate is close to 15 % (Demirag et al., 2006). The pathophysiology of acute pancreatitis is 
incompletely understood but alteration in the pancreatic microcirculatory blood flow has 
been involved. Thus, a decrease in pancreatic blood flow occurs early in the course of acute 
pancreatitis and has been suggested to play a role in the conversion of edematous to 
necrotizing acute pancreatitis (Klar et al., 1994). The microcirculatory dysfunction includes 
arterial vasoconstriction with hypoperfusion, ischemia-reperfusion injury and obstruction of 
the venous outflow (Klar et al., 1991; Letko et al., 1994; Demirag et al., 2006).  
Besides perfusion abnormalities, acute pancreatitis is also characterized by local and 
systemic inflammatory responses, including leukocyte activation as well as release of free 
radicals and cytokines (Frossard et al., 2001). Many therapeutic agents, such as  dextran, 
heparin, procaine, L-arginine, antioxidants, or cytokine antagonists, have been tested 
experimentally and/or clinically to improve pancreatic tissue perfusion during acute 
pancreatitis, however, no significantly successful result has been achieved (Beger et al., 2001, 
Paszkowski et al., 2001). Epidural anesthesia that is used to induce analgesia in the 
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perioperative period might be an interesting treatment of the microcirculatory blood flow 
abnormalities (Demiraget al., 2006). 
2.4 Type of surgical intervention 
Severe acute pancreatitis is still related to high mortality rates. Over the past decades, 
management of severe acute pancreatitis changed from an early operative treatment to a 
more conservative approach. Surgical debridement is the gold standard in patients with 
infected pancreatic necrosis. However surgical intervention for sterile necrosis is only 
indicated in selected patients if aggressive intensive care is unsuccessful. Patients suspected 
to have infected pancreatic necrosis, should undergo computer tomography-guided or 
ultrasound-guided fine-needle aspiration for verification. By delaying surgery up to the 
third week, sufficient debridement can be achieved by a single operation, resulting in low 
mortality and morbidity rates. 
2.4.1 Operative treatment of pancreatic necrosis 
In patients with infected pancreatic necrosis, surgical necrosectomy is the established gold 
standard, whereas operative treatment of patients with sterile necroses is controversially 
discussed. Surgical debridement of infected pancreatic necrosis is based on two principles 
(Sahora et al., 2009). First, necrotic pancreatic tissue as well as pancreatic ascites is removed 
out of the peritoneal cavity and the lesser sac, to prevent absorption through the thoracic 
duct, which is accused to increase the incidence of systemic complications as development 
of single or multiple organ failure (Mayer et al., 1985). Second, as much as possible viable 
pancreatic tissue should be preserved to insure a good quality of life after recovery (Broome 
et al., 1996). Nowadays mortality in patients with infected pancreatic necrosis is about 10–
30% in specialized centers as a result of right timing and patient selection (Büchler et al., 
2000). Because of improvements in intensive care medicine, today more patients survive the 
first phase of acute pancreatitis, increasing the incidence of infected necrosis (Beger et al., 
1986). Retroperitoneal gas or bacterial culture gained from fine-needle aspiration 
(ultrasound or computer tomography guided) is confirmation for infected pancreatic 
necrosis. Sterile necrosis, in general, is no indication for surgery. Multiple series have shown 
that patients with sterile necrosis can be managed by a conservative approach, but surgery 
might be indicated in case of late complications, disease progression or persistence. In these 
severely ill patients, who develop organ failure without signs of septic complications, the 
indication to surgery must be made individually (Sahora et al., 2009). As in patients with 
infected necrosis, early operation has shown high mortality rates and should also be delayed 
upon the third week (Büchler et al., 2000; Uhl et al., 2002; Hartwig et al., 2002a). 
In the past, early surgical intervention was indicated for patients with severe acute 
pancreatitis, but was lead to mortality rates up to 65% (Smadja & Bismuth, 1986). The aim of 
this intervention was that patients would benefit from the initial removal of necrotic tissue, 
leading to the reduction of multisystemic complications related to enzymes and toxic 
substances (Fernandetz –Cruz et al., 1994). For evaluation of mortality rates, early surgical 
intervention was compared to a more conservative approach. In retrospective study 
performed by Hartwig et al., and in randomized control trial made by Mier et al., was found 
reduction of mortality rates in patients undergoing delayed surgery (Mier et al., 1997; 
Hartwig et al., 2002a).  
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At present, guidelines for the management of surgical treatment of severe acute pancreatitis 
agree that surgical intervention should be delayed as long as 3–4 weeks after onset (Uhl et 
al., 2002; Isaji et al., 2006). By deferring surgery a proper demarcation of pancreatic and 
peripancreatic necrosis can take place. The demarcation of necrotic masses from viable 
tissue enables an easier and safer debridement with a greater likelihood of sparing 
pancreatic tissue and leads to successful surgical control of pancreatic necrosis. Thus the risk 
of bleeding and the surgery-related loss of vital tissue that predisposes to surgery-induced 
endocrine and exocrine pancreatic insufficiency can be minimized by this approach 
(Hartwig et al., 2002b, Bober et al., 2003).  
The aim of any intervention technique is to maximize debridement, preserve as much vital 
pancreatic parenchyma as possible and to secure postoperative drainage of debris and 
exudates (Götzinger et al., 2002). Resection procedures, as partial or total pancreatectomy, 
which also remove vital tissue, have been abandoned, because of impaired quality of life 
and higher mortality and morbidity (Nordback & Auvinen, 1985). Several open and 
minimal invasive techniques have been described, but an ideal method has not yet been 
defined. The surgical procedures including: open necrosectomy with closed continuous 
lavage, open necrosectomy with drainage and relaparotomy on demand, open 
necrosectomy with open packing and planned re-laparotomy. However morbidity (80%), 
including pancreatic, intestinal fistula, stomach outlet stenosis, local bleeding, and incisional 
hernia, is higher in patients undergoing multiple relaparotomies, which are mandatory in 
open packing procedure (Beger et al., 1982; Büchler et al., 2000; Fernandez-del Castilo et 
al.,1998).  
The open approach for the surgical treatment of severe acute pancreatitis including blunt 
debridement is combined with laparostomy for drainage and access for revisions to further 
remove local debris. Operative access is gained by a way of a midline incision. Careful 
exploration is done to assess the extent of pancreatic and extrapancreatic necrosis, including 
a Kocher’s mobilization of the second part of the duodenum. Furthermore the right and the 
left colon are mobilized. It is possible to approach the lesser sac through the gastrohepatic 
omentum or the gastrocolic omentum. If opening of the lesser sac is not possible because of 
a bounded inflammatory process, direct access from the infracolic compartment via the left 
transverse mesocolon is an alternative. The access through the mesocolon also allows drains 
to be placed in a more exact position once the debridement is completed. It is important to 
send fluid collection from the necrotic region for aerobic and anaerobic culture (Sahora, 
2009). After sufficient debridement there remain cavities, which are often stiff and may 
bleed from the granulated surface. In these spaces is necessity to place 4–10 easy flow 
drains, which are brought out through left and or right side placed laparostomas. These 
drains are not removed unless the daily quantum of fluid loss is less than 20 ml. Another 
possibility is to stepwisely remove these drains that will result in a fistula due to a mature 
fistula tract. This fistula will close in a given period (Sahora et al. 2009).  
Today several additional techniques to open surgical necrosectomy have been described. 
Percutaneous drainage, endoscopic techniques, and minimal invasive surgical procedures 
have been described as additive and alternative procedures. Percutaneous computer 
tomography-guided catheter debridement without surgery has been shown to be feasible in 
selected series in more than 50% of the included patients, with infected and sterile necrosis. 
Mortality rates of 12–30%, of patients treated by percutaneous drainage only, have been 
reported, using different access routes and a variety of catheter types (Bruennler et al., 2008; 
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Mortelé et al., 2009). The major reported complications were hemorrhage and injury to 
adjacent organs. The endoscopic drainage of sterile pancreatic necrosis using several 
transgastric and transduodenal catheters combined with a nasopancreatic catheter to lavage 
the necrotic cavity described Baron in 1996 (Baron et al., 1996). Using endoscopic drainage, 
many authors reported a high percentage of patients, who were treated without the need of 
surgery (Baron et al., 2002, Seifert et al., 2009, Seewald, 2005). Recently also minimally 
invasive necrosectomy techniques have been used with some promising results. Different 
approaches are described to access the necrotic mass. Some authors prefer a transabdominal 
access, which offers a good overview but harbors the risk of spreading intra-abdominal 
infection. As an alternative the necrotic focus can be reached through retroperitoneoscopy. 
Bücher et al. reported a group of 8 patients who underwent minimal invasive necrosectomy 
using a single large port, inserted over the percutaneous drainage channel. Complication 
rate was zero and despite one patient only a single session was needed (Bucher et al., 2008). 
Alternatively Parekh describes a laparoscopic hand-assisted method, using 
a transabdominal approach. In this series 19 patients, out of 23, were treated without the 
need of open laparotomy, zero postoperative complications, and a mortality of 10.5% 
(Perehk, 2006).  
In conclusion, comparison of these minimal invasive procedures is almost impossible 
because of inhomogenity of patient selection. Today there are no randomized controlled 
trails comparing open surgery to one of the mentioned methods. Minimal invasive 
procedures may play a role in bridging the time to definite surgery in critically ill patients in 
some well-experienced clinical centers (Sahora et al., 2009). 
2.4.2 Intra-abdominal hypertension 
Intra-abdominal hypertension is increasingly reported in patients with severe acute 
pancreatitis, and is caused by several factors, including visceral edema and ascites 
associated with massive fluid resuscitation, paralytic ileus and retroperitoneal 
inflammation. There is a strong relation with early organ dysfunction and mortality in these 
patients, which makes intra-abdominal hypertension an attractive target for intervention. 
Several reports conclude that this phenomenon occurs within the first 5 days after 
admission, and that the kinetics of inta-abdominal hypertension is important: patients with 
persistent intra-abdominal hypertension seem to be at the highest risk for mortality. Several 
strategies to reduce intra-abdominal pressure have been developed, and given the 
pathophysiology, percutaneous drainage of ascites is a first logical step. However, if 
conservative measures fail to reduce intra-abdominal pressure in a setting with ongoing or 
worsening organ dysfunction, abdominal decompression is recommended.  Intra-abdominal 
hypertension and intra-abdominal compartment syndrome have been described most often 
in patients with abdominal trauma or after emergency abdominal surgical procedures such 
as aortic aneurysm repair (De Waele, 2008). The intra-abdominal hypertension is defined as 
a sustained or repeated pathologic elevation of the intraabdominal pressure above 12mm 
Hg. The intra-abdominal compartment syndrome is described as the sustained elevation of 
intra-abdominal pressure above 20mmHg in combination with newly developed organ 
dysfunction (Malbrain et al., 2006). 
It was shown that intra-abdominal hypertension is associated with higher mortality and 
morbidity rates, and prolonged intensive care unit stay, in comparison to other patients who 
had normal intra-abdominal pressure (Sugrue et al., 1999). Intra-abdominal hypertension has 
been recognized as a cause of organ dysfunction in critically ill patients, including those 
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suffering from severe acute pancreatitis (Balogh et al., 2002). Placement of a urinary catheter 
for the monitoring of intra-abdominal pressure would be necessary in the severe acute 
pancreatitis patients. The symptoms caused by intra-abdominal hypertension in patients with 
acute pancreatitis are not very different from other conditions associated with intra-abdominal 
hypertension. Hemodynamic instability requiring vasoactive drugs, acute renal failure and 
respiratory failure are the most obvious clinical signs and symptoms that have been associated 
with intra-abdominal hypertension.  The association between intra-abdominal hypertension 
and development of organ dysfunction in severe acute pancreatitis is well documented. De 
Waele et al. showed that there was a 95% incidence of respiratory failure, 91% cardiovascular 
and 86% acute renal failure rate in patients with intra-abdominal pressure of 15 mmHg or 
higher (De Waelle et al., 2005).  The development of intra-abdominal hypertension in patients 
with severe acute pancreatitis is evidently an important problem, as it is associated with organ 
dysfunction and mortality. Therefore, intra-abdominal pressure should be measured routinely 
in patients admitted to the intensive care unit with severe acute pancreatitis, and intra-
abdominal pressure should be considered a target for intervention in all patients.  
Decompressive laparotomy has been shown to effectively reduce intra-abdominal pressure 
and reverse the symptoms typically associated with abdominal compartment syndrome (De 
Waelle et al., 2006; Dambrauskas et al., 2009). If decompression is needed more than 2–3 
weeks after the onset of the disease and there is evidence of extensive necrosis on a 
computered tomography scan or established infection of peripancreatic necrosis, it is the 
feasible to perform a necrosectomy in conjunction with the decompressive laparotomy. In 
selected patients with extensive retroperitoneal fluid collections, a lumbotomy may provide 
access to the retroperitoneal space, and allow evacuation of pancreatic necrosis as well. The 
management of the open abdomen following decompression in severe acute pancreatitis is 
challenging. The best currently available technique is the utilization of the vacuum-assisted 
closure technique aiming for gradual closure of the abdominal wall. The use of a vacuum 
assisted closure system guarantees a perfect seal of the peritoneal cavity, avoiding possible 
superinfection of the pancreatic or peripancreatic necrosis.  
Intra-abdominal hypertension seems to have a significant role in contributing to the early 
multi organ dysfunction syndrome, subsequent complications and mortality in severe acute 
pancreatitis. Intra-abdominal pressure monitoring is mandatory for all patients who 
develop organ dysfunction, and intra-abdominal pressure should be a target for 
intervention when intra-abdominal hypertension and organ dysfunction persist. Surgical 
decompression should be considered in all patients with persistent organ dysfunction after 3 
days or later (Sugrue et al., 2007; De Waele, 2008). 
3. Clinical group of patients and the methods 
All patients who were hospitalized due to the acute pancreatitis symptoms in the period 
from January 2003 till December 2008 at the First Department of Surgery, University 
Hospital, in Kosice, were included to this study. Those patients, who were primarily 
hospitalized and treated at other workplaces and were moved to our institute during their 
disease, were excluded from this study.  
The total number of the patients with acute pancreatitis during onset symptoms was 258 
ones. All patients were hospitalized at the Intensive Care Unit, they received the standard 
intensive care (palliation of pain, nasal gastric tube, central vein catheter, urinary bladder 
catheter, intensive monitoring of the basic vital functions, intensive rehydratation treatment, 
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giving the inhibitors of proton pump, low molecular weight heparin, giving the 
prophylactic antibiotic therapy). In the case of biliary acute pancreatitis, mainly joined with 
jaundice, cholangitis or ultrasound suspicion for the presence of the stones in common bile 
duct, the patients were underwent urgent endoscopic retrograde cholangio-
pancreatography during the first 48 hours after onset acute pancreatitis. The distinguishing 
of the mild forms and severe forms of acute pancreatitis were carried out using Ranson 
criteria, APACHE score, the daily follow-up of level C-reactive protein and measurement of 
percentage of involvement of pancreatic tissue by computer tomography severity index 
(Balthazar computer tomography scoring system). The first computer tomography 
examination was carried out first time after 48 hours from the beginning of disease. The 
diagnosis of the infected necrosis we did according to the clinical finding, inflammatory 
markers (white blood cells, C-reactive protein, procalcitonin), and ultrasound and computer 
tomography finding (presence of gas bubbles). 
Patients with multi organ failure were moved from the Intensive Care Unit to be 
hospitalized at the Department of Anesthesiology and Intensive Medicine of our institute.  
The clinical group of hospitalized patients was divided into two subgroups. Group A 
included the patients hospitalized from January 2003 till December 2005. This group of 
patients was evaluated retrospectively. The second Group B included the patients 
hospitalized from January 2006 till December 2008. This group was studied prospectively, 
according to the clinical protocol prepared in advance, which reflected the changes in 
management of the patients with the severe acute pancreatitis after confirmation of necrosis.  
Fisher’s exact and Pearson chi-square tests were used in data analysis. P < 0.05 was 
considered statistically significant. 
3.1 Clinical protocol of changes in management of treatment acute pancreatitis 
patients 
Enteral nutrition fed by the three-luminal tube applied by fibroscope, checking the position 
by the contrast X-rays exam or by enteral nutrition through jejunostomy, in the case of 
already operated patients. Enteral nutrition was applied if no signs of the cardiovascular 
instability were present. We used the enteral nutrition enriched of the glutamine, arginine 
and omega-3 fatty acids and fibres. The dose was gradually increased from 20ml/hour to 
80ml/hour (maximum 1000ml/24 hours). The enteral nutrition was started at seven o´clock 
in the morning and takes 12.5 hours to half past seven in the evening. At night, the enteral 
nutrition was not administrated. The second change includes an application of the epidural 
catheter to palliate the pain and to recovery of intestinal peristaltic. The continual 
measurement of the intra-abdominal pressure with the catheter in urinary bladder was 
used. The changes in the prophylactic application of antibiotics include changing 
III.generation cephalosporin’s which were administered in Group A for imipenem which 
were replaces in Group B. In both groups the prophylactic application lasted maximum 14 
days. Necrosectomy was indicated and performed as late as possible; usually the surgical 
procedure was pushed to the third or fourth week of hospitalization.  
3.2 Results 
Basic characteristic of both subgroup A and B are documented in table 1. It follows less 
frequency in Group A, however the male/female ratio and occurrence of the severe acute 
pancreatitis was similar. The percentage of the patients with necrotic pancreas and the 
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patients, who needed endoscopic retrograde cholangiography procedure, was similar as 
well.  
 
 Group A Group B 
Number of patients 97 161 
Male/Female 53 : 44 90 : 71 
Mild acute pancreatitis 84 (86%) 132 (82%) 
Severe acute pancreatitis 13 (14%) 29 (18%) 
Number of patients + endoscopic 
retrograde 
cholangiopancreatography 
 
34 (35%) 
 
53 (33%) 
Table 1. Groups of patients suffered from acute pancreatitis, group A (2003-2005), group B 
(2006-2008). 
Further we will be concerned only with the patients with severe acute pancreatitis. More 
detailed characteristic of patients with severe acute pancreatitis is documented in table 2. 
 
 Group A Group B 
Number of patients 13 29 
Male/Female 8/5 16/13 
Mean of age 38,5 year 42 year 
Etiology of acute pancreatitis 
Alcohol 
Biliary disease 
Other 
 
7 (54%) 
5 
1 
 
14 (48%) 
12 
3 
Ranson score 3,9 (3-9) 4,0 (2-9) 
Number of patients with computer tomography scan 
necrosis more than 30% 
 
12 (92%) 
 
26 (90%) 
Patients hospitalized at the Department of 
Anesthesiology et Intensive Medicine  
 
6 (46%) 
 
11 (37%) 
Table 2. Group of patients suffered from severe acute pancreatitis 
More detailed description of group of patients with severe acute pancreatitis is documented 
in table 2. In both groups of patients there is a dominance of male and the similar average 
age, Ranson score, as well as a number of patients with necrotic pancreas over than 30%. 
Alcoholic etiology occurred more often in Group A. Also we noticed the higher number of 
patients, who needed hospitalization at the Department of Anesthesiology and Intensive 
Medicine. During the hospitalization, mainly during the period from 72 hours to 7th day, we 
provided intensive treatment in both group of patients, however in some cases in spite of 
our intensive effort, the multi organ failure occurred. In the case of presence of abdominal 
compartment syndrome, we indicated the surgical intervention including intra abdominal 
decompression. Presence of the infected pancreatic necrosis or abscess was a clear indication 
for surgical intervention. Individual indications and the timing of the surgery are presented 
in table 3. 
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 Sterile necrosis + 
multi organ 
failure 
Infected  
necrosis 
Abscess Together Mortality  
 
Time A B A B A B A B A B 
Till 72 hours 1 1     1 1 1 1 
Till 7 days  3 2     3 2 3 1 
After 7 days  1 1    1 1   
After 14 days   1 3   1 3 1 1 
After 21 days   1 4  1 1 5   
Together 4 4 3 7  1 7 12 5 
71% 
3 
25% 
Table 3. Timing of surgery, surgical indication and mortality in group A and group B. 
In Group A, it is shown more often indications to the surgical intervention in the first days 
and weeks of hospitalization period. Comparing Group B, mainly in the case of infected 
necrosis, the surgical operations were pushed to the third or fourth week. This was reflected 
also in the mortality of operated patients, when we recorded 71% mortality in Group A and 
25% of mortality in Group B. The types of surgical procedures are documented in table 4. 
While during the first days we performed only the surgical revision and drainage, or open 
abdomen. In the case of infected necrosis we performed necrosectomy with closed 
continuous lavage. There are also documented the number of patients with reoperations in 
both groups of patients, which is less frequent in Group B.  
 
 Primary surgery Repeated surgery Mortality 
Type of surgery A B A B A B 
Revision, drainage, open 
abdomen, jejunostomy 
2 1 
 
0 
 
0 2 0 
Revision, drainage, 
jejunostomy 
1 
 
4 1 0 0 3 
Necrosectomy, 
continuous lavage 
4 7 2 4 3 0 
Together 7 12 3 (43%) 4  (33%) 5 3 
Table 4. Type of surgical procedures and mortality of patients in group of patients A and B. 
The mortality in both groups of patients is presented in the Table 5. It shows less mortality 
in Group B (18%). Six patients were found with non infected necrosis 46% in Group A (2003-
2005), but seventeen patients were documented with non infected necrosis 58% in Group B 
(2006-2008). 
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 Number of patients Mortality 
 A B A B 
Acute pancreatitis patients  97 161 7 (7.2%) 5 (3.1%) 
Severe acute pancreatitis 
patients 
13 29 7 (53.8%) 5 (18%) 
Severe acute pancreatitis 
patients after surgery 
7 12 5 3 
Severe acute pancreatitis 
patients with non infected 
necrosis 
6 17 2 2 
Table 5. Comparison of mortality of patients in group of patients A and B. 
The comparison of the cause of the death in both groups is presented in table 6. There was 
statistically significant decrease in mortality in group of patients B (p=0.02).While only 2 
patient’s dead for the pancreatic sepsis with multi organ failure, the remainder 10 patient’s 
dead for multi organ failure in first days after the admitting to hospital. 
 
 Group of patients A  
(2003-2005) 
Group of patients B  
(2006-2008) 
 
P 
Number of patients  13 29 - 
Death 7 (54%) 5 (18%) 0.02 
Multi organ failure 6 (85%) 4 (80%) - 
Pancreatic sepsis 1 (15%) 1 (20%) - 
Table 6. Cause of death in both groups of patients A and B. 
4. Discussion 
Despite of the lasting dissatisfaction with the mortality level of the patients with severe 
acute pancreatitis, nevertheless during last decades as a consequence of the positive shift in 
diagnostic methods and treatment of acute pancreatitis, we succeeded to decrease mortality 
of severe acute pancreatitis patients to 10%-20% (Del Campos et al., 1998). During the last 15 
years a big step was done towards the understanding and development of acute pancreatitis 
and at the same time the great progress in the screening methods of pancreas (Uhl et al., 
2002). In line with the other authors opinions (Bank et al., 2002), taking into account own 
experiences, we are convinced that the decrease of the mortality was causes by an early 
recognition of the severe acute severe and setting up the prompt and appropriate treatment, 
by the improvement of the nutritional support, early endoscopic retrograde 
cholangiopancreatography supplied to the accurately indicated patients, and using the 
effective antibiotic treatment.  
The International Association of Pancreatology proposed for acute pancreatitis treatment 
eleven recommendations (Sarr, 2003; Uhl et al., 2002), which created the framework for 
contemporary management of acute pancreatitis. These recommendations are based on the 
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principles of evidence based medicine. However, in many points, there is need of further 
comparative studies was observed.  
Positive trend of the decreasing mortality in the cases of severe acute pancreatitis was 
visible also at our workplace. These results have been already published previously (Bober 
et al., 1995; Bober et al., 2002; Bober et al., 2003). During the period from 2003 to 2005 the 
results overall got worse, when the mortality level of severe acute pancreatitis increased to 
53.8%. After in-depth analysis of the causes of this negative result, the decision to change 
management of the patients with acute pancreatitis was made. The new protocol was 
designed, which contained the change of the management.  
The contemporary standard of management of acute pancreatitis is the intensive 
conservative treatment with possibility of the diagnosis of its complications in the course of 
the therapy (Huťan, 2006). Very important part of the acute treatment is early and adequate 
fluid resuscitation during the first hour after admission in the case of patients with 
cardiovascular instability. When diagnosis of acute pancreatitis is confirmed, the treatment 
in line with a new protocol was applied.  
Many reports were published about the positive influence of the early enteral nutrition in 
the case of severe acute pancreatitis. Cao et al. published the results of meta-analysis, which 
compared the results achieved by the enteral nutrition and total parenteral nutrition in the 
case of severe acute pancreatitis. Patients with enteral nutrition have shown less risk of 
infection, less percentage of pancreatic and peripancreatic necrosis, as well as, less overall 
complications, less often multi organ failure and low mortality (Petrov et al., 2006; Cao et al., 
2008). Application of the three-luminal tube with help of fibroscope was carried out in our 
Group B by own co-workers, who had enough experiences and own endoscopy certificate. 
The application of the gastric aspirate and the enteral nutrition was tolerated well by all 
patients. Some of them perceived the abdominal discomfort and the slight increasing of the 
intra abdominal pressure. In these cases we have temporarily reduced the volume of the 
enteral nutrition.  
The aim of the prophylactic application of antibiotics is to protect the sterile necrotic tissue 
against the development of infection. In general, it is accepted, that 40%-70% necrosis is 
infected. With regard to the high percentage of this infection of pancreatic necrosis and with 
regard to the fact that mortality is higher in the case of infected necrosis than in the case of 
sterile ones, the preventive application of antibiotics prevention, which has to avoid the 
infection of the necrosis. The reason is except an unproved benefit from prevention also its 
possible risks (antibiotic resistance and development of mycotic super infection from 
antibiotics) (Dambraukas et al., 2007; Dellinger et al., 2007; Olejník & Brychta, 2008). At 
present, the routine application of the prophylactic antibiotics to the patients with proven 
necrosis, has many supporters (Xu & Cai, 2008; Rokke et al., 2007; Dambraukas et al., 2007; 
Otto et al., 2006; Uhl et al., 2002). The conclusions of their studies show that antibiotics 
prevention reduces the sepsis and mortality. The recommendation in International 
Association of Pancreatology reports that prophylactic application of broad-spectrum 
antibiotics reduces infection of computer tomography confirmed necrotic acute pancreatitis, 
but it does not improve survival rate. When choosing the antibiotics, it is pointed at the best 
results Imipenem or Meropenem (decrease of necrosis, less necessities to surgical treatment, 
lower mortality) (Carter et al., 2000). Comparing Imipenem and Meropenem, no differences 
in incidence of the septic complications were observed (Heinrich et al., 2006). Preventive 
antibiotics have to be administered during 7-14 days. Longer applications than 14 days is 
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not recommended (Olejník & Brychta, 2008). Regarding the different opinions on the 
antibiotics prophylaxis, it is necessary to take into account the extent of necrosis of the 
pancreas. If the damage is less than 30% of pancreas parenchyma, the risk of infection is 
small (Olejník & Brychta, 2008). Despite of all contra version, many, also prestigious 
workplaces, at present administer the antibiotics prophylaxis in the case of severe acute 
pancreatitis, bearing the risk of contra productive effect. We assigned our workplace to this 
group.  
In the cases of patients with severe acute pancreatitis, it is necessary from the beginning or 
during the treatment, in spite of the intensive conservative one, to consider the indication of 
the surgical treatment. During the initial phase after admission of patients with acute 
pancreatitis the situations appear, when in spite of the precise differential diagnostics (based 
on anamnesis, clinical examination, laboratory tests, ultrasound) these does not bring the 
clear breaking up and the indication of diagnostic exploration can be actual. Computer 
tomography examination can be very helpful in such situations and it can decrease these 
doubt to minimum. Despite of the risk of surgery, the published opinions say, that it is less 
probable, that the diagnostic exploration exacerbated local inflaming process, though it can 
increase the risk of infection of pancreatic necrosis. This risk should be reevaluated in 
situation, when there is no other alternative approach in treatment without surgical 
intervention (Dugernier et al., 2006).  
The indications for surgery which are also now discussed are the patients with sterile 
pancreatic necrosis and multi organ failure, which are non-responsible to the intensive 
treatment more than 72 hours. In the literature, there is a published opinion, that patients 
with high extent of pancreatic necrosis with persistent multi organ failure, in spite of 
maximum intensive care, can have a benefit from surgery. The clinical status has to be 
revaluated daily, because the right timing of surgical intervention is very important. 
Intensive care is suitable until the indications for surgical solution are not fulfilled 
(Götzinger et al., 2002). 
In our group of patients we indicated the surgical treatment for 7 patients in 7 days after 
admission to hospital. In this group of patients, we recorded 86% mortality (in Group A 
100%, in Group B 67%). Some authors recommend surgical intervention to the patients with 
sterile necrosis, whose status is not improved during four weeks of intensive care (Hartwig 
et al., 2002b).  
A right timing of necrosectomy is discussed up till now. Those, who propose an early 
surgery say, that patient benefits from the early removal of the tissue necrosis, as it results to 
the decreasing of the multisystem complications linked with the releasing of enzymes and 
toxic substations. In the past, an early surgical intervention was preferred especially in the 
cases of system functions damage, but it resulted to the high mortality (Götzinger, 2007). 
Götzinger study pointed at the fact that a benefit from the delay of the surgical intervention 
is in the enclosure of demarcation process of dead tissue. This demarcation enables the safe 
and sufficient following debridement, which leads to be successful surgical control of 
pancreatic necrosis in one or more steps. The analysis of the timing showed, that 
necrosectomy performed after three weeks from the beginning of illness is linked with 
higher percentage of success of debridement of pancreatic necrosis, what results to the lower 
number of reoperation and lower mortality. Very early debridement (up to three weeks) 
means an oversize percentage of mortality (Götzinger, 2007). 
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In rare situation, also intra-abdominal hypertension is an indication to decompressive 
laparotomy (Šiller et al., 2007). Intra-abdominal hypertension is caused by paralytic ileus, by 
large inflammation of retroperitoneal tissue, increased vascular permeability and also by 
liquid collections in abdominal cavity. It can be caused also by aggressive liquid hyper 
resuscitation (Dugernier et al., 2006). 
Intra-abdominal hypertension is typical at the beginning of illness and can lead to the intra-
abdominal compartment syndrome (the intra-abdominal pressure is higher than 20mmHg), 
which can make worth organ dysfunctions (Malbrain et al., 2006). 
At present some indications to surgical treatment are apparent and clear. The absolute 
indications to the urgent surgery are necrosis and pancreatic or peripancreatic abscess. 
Infected necrosis begins at 40-50% patients with necrotic acute pancreatitis (Hartwig et al., 
2002b). Infected necrosis means the necrotic area with bacterial contamination in devitalized 
tissue. Necrosis of pancreas and peripancreatic tissue is the risky environment for bacterial 
contamination. The risk of pancreatic infection grows with the volume of devitalized tissue. 
It culminated in the third week from the beginning of the illness. But 25% of patients have 
the infection during first 7 days (Dugernier et al., 2006). 
Although acute pancreatitis is at the beginning a sterile inflammatory disease, which leads 
to multi organ dysfunctional syndrome, so the clinical features are difficult to distinguish 
from severe sepsis. The confirmation of presence of infection is when gas bubbles are found 
on the computer tomography examination, also by the positive cultivation of specimen 
obtained from the necrosis by thin-needle technique. This technique is safe and 90% precise 
(Schmid et al., 1999). 
Bacterial translocation from intestinal lumen (transmurally, by lymphatic and vascular way, 
by ascites) is the main mechanism of the infection transfer to the necrosis during the first 
weeks of the disease. The microbiological examination shows that the origin of infection of 
pancreas is first of all the intestinal infections. Later sources are nosocomial infections of 
staphylococcus and enterococcus, including the multiresistant microorganism and mycotic 
infections (Büchler et al., 2000). At present, the accepted opinion is that necrosectomy has to 
be done as soon as the evidence of the infected necrosis is confirmed (Huťan, 2008).  
The approach of the surgical treatment of necrotic acute pancreatitis has been developed. 
Some of them are obsolete (resection methods), but various techniques of the necrosectomy 
of pancreatic and peripancreatic necrosis remain as dominant approach done by the classic 
open surgery, by laparoscopic retroperitoneal miniinvasive surgery or percutaneous 
necrosectomy. 
Additional techniques (after necrosectomy) are based on knowledge, that during surgical 
intervention it is not possible to remove all necrosis, because demarcation is not complete 
and too radical removal of this necrosis causes rather damage than benefit. On the other 
hand the rest of the necrosis can be a source of the persistent sepsis.  
From the range of additional techniques may be mentioned the conventional surgical 
drainage with closing of the abdominal cavity and with location of the gravity or suck tube 
drains, open abdomen techniques also called laparostomy and at last the closed continuous 
lavage. It is possible to combine to abovementioned additional techniques.  
Own experiences with all additional technique have been published already (Bober et al., 
2003). At present we use all of them, but we prefer the closed continuous lavage technique 
of bursa omentalis and retroperitoneum, as we published in 2003, accepting also results of 
comparative studies (Beger et al., 2002; Branum et al., 1998). 
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Delay of the necrosectomy to the third –fourth week of hospitalization with applying the 
closed continuous lavage we obtained very good results in number of postoperative local 
complications as well as in the need of reoperations and no mortality in this subgroup of 
patients. 
During last year’s many works were published about retroperitoneal necrosectomy (Connor 
et al., 2005; Van Santvoot et al., 2007) laparoscopic assisted percutaneous drainage of 
infected necrosis and peripancreatic abscess (Horvath et al., 2001), laparoscopic 
necrosectomy (Cushieri et al., 2002; Risse et al., 2004; Šutiak et al.,2008). Also other authors 
published the report about very positive results with percutaneous necrosectomy (Bruennler 
et al., 2008; Hartwig et al., 2002a). The benefit of percutaneous necrosectomy is mini invasive 
approach, which does not require total anesthesia, but the disadvantages are: longer time of 
hospitalization, higher doses of X-ray because of repetitive computer tomography controls 
and high percentage of cases, when patients had to perform of laparotomy due to the 
insufficiency of previous one.  
Pancreatic abscess contrary to the infected necrosis is well demarcated collection of purulent 
liquid without solid necrotic material. It is a result of infection, which arises from 
accumulation of liquid collections or from the area of necrosis, which has liquidized in the 
meantime. Comparing with the infected necrosis, the pancreatic abscess appears later (more 
than four weeks from the beginning of a disease) and the prolonged process is typical for it 
(Fernandez Del Castilo et al., 1998). If the pancreatic abscess contains small, solids particles, 
very often it is not suitable to drain it in percutaneous or endoscopic way (Baril et al., 2000; 
Carter et al., 2000). 
The other indication for surgery is the course of severe acute pancreatitis is bleeding. The 
intensive inflammation, large regional necrosis and secondary infection cause arouses of 
great vessels and cause a pseudoaneurysm, which rupture may cause massive hemorrhage 
to gastrointestinal tract, retroperitoneum or abdominal cavity. 
The early diagnosis and following intervention radiology and surgical treatment are 
necessary for bleeding control. Debridement of the infected necrosis is the effective 
management for minimizing the risk of recurrent bleeding. Fortunately, the incidence of the 
hemorrhagic complications of severe acute pancreatitis decreases due to early recognition 
and intensive treatment of these patients (Huťan, 2008).  
5. Conclusion 
Despite the mortality of severe acute pancreatitis decreased after the implementation of new 
diagnostic and medical procedures in last two decade, many questions are still open. Recent 
studies of severe acute pancreatitis were reviewed and the decision to change the 
management of the treatment of severe acute pancreatitis has been made. The management 
referred to the enteral nutrition, epidural analgesia, antibiotic prophylaxis, delay surgery to 
the later period (three-four weeks after onset) in the case of infected necrosis.  
Using enteral nutrition in preventing septic complications of acute pancreatitis seems to be 
better than parenteral nutrition. Epidural anesthesia is used to induce analgesia, to recovery 
of intestinal peristaltic and for improvement of the microcirculation blood flow. The 
continual measurement of the intra-abdominal pressure with the catheter in urinary bladder 
was used. After confirmation of necrosis, the prophylactic application of antibiotics 
including imipenem was used for severe acute pancreatitis patients. The prophylactic 
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application lasted maximum 14 days. By deferring surgery a proper demarcation of 
pancreatic and peripancreatic necrosis can take place. The demarcation of necrotic masses 
from viable tissue enables as easier and safer debridement with a great likelihood of sparing 
pancreatic tissue and leads to successful surgical control of pancreatic necrosis. 
Applying the change of the management of treatment of the patients with the complicated 
form of acute pancreatitis, there were found an interesting results, which could 
recommended to use this management for patients suffered from severe acute pancreatitis.  
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